322
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Targeted delivery of large fusion protein into hippocampal neurons by systemic administration

, , , , &
Pages 632-636 | Received 07 Jun 2010, Accepted 05 Sep 2010, Published online: 11 Oct 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jennifer K. Saucier-Sawyer, Yang Deng, Young-Eun Seo, Christopher J. Cheng, Junwei Zhang, Elias Quijano & W. Mark Saltzman. (2015) Systemic delivery of blood–brain barrier-targeted polymeric nanoparticles enhances delivery to brain tissue. Journal of Drug Targeting 23:7-8, pages 736-749.
Read now
Susanne Rohn, Anne Suttkus, Thomas Arendt & Uwe Ueberham. (2012) RVG peptide as transfection reagent for specific cdk4 gene silencing in vitro and in vivo. Journal of Drug Targeting 20:4, pages 381-388.
Read now

Articles from other publishers (23)

Nguyễn Thị Thanh Nhàn, Tohru Yamada & Kaori H. Yamada. (2023) Peptide-Based Agents for Cancer Treatment: Current Applications and Future Directions. International Journal of Molecular Sciences 24:16, pages 12931.
Crossref
Vinod Kumar, Sumeet Patiyal, Rajesh Kumar, Sukriti Sahai, Dilraj Kaur, Anjali Lathwal & Gajendra P. S. Raghava. (2021) B3Pdb: an archive of blood–brain barrier-penetrating peptides. Brain Structure and Function 226:8, pages 2489-2495.
Crossref
Sanjay Arora & Jagdish Singh. (2021) In vitro and in vivo optimization of liposomal nanoparticles based brain targeted vgf gene therapy. International Journal of Pharmaceutics 608, pages 121095.
Crossref
Atefeh Rayatpour & Mohammad Javan. (2021) Targeting the brain lesions using peptides: A review focused on the possibility of targeted drug delivery to multiple sclerosis lesions. Pharmacological Research 167, pages 105441.
Crossref
Qinghua Wang, Shang Cheng, Fen Qin, Ailing Fu & Chen Fu. (2021) Application progress of RVG peptides to facilitate the delivery of therapeutic agents into the central nervous system. RSC Advances 11:15, pages 8505-8515.
Crossref
A. Zaghmi, J. Drouin-Ouellet, D. Brambilla & M.A. Gauthier. (2021) Treating brain diseases using systemic parenterally-administered protein therapeutics: Dysfunction of the brain barriers and potential strategies. Biomaterials 269, pages 120461.
Crossref
Bruna dos Santos Rodrigues, Sanjay Arora, Takahisa Kanekiyo & Jagdish Singh. (2020) Efficient neuronal targeting and transfection using RVG and transferrin-conjugated liposomes. Brain Research 1734, pages 146738.
Crossref
Jinbing Xie, Zheyu Shen, Yasutaka Anraku, Kazunori Kataoka & Xiaoyuan Chen. (2019) Nanomaterial-based blood-brain-barrier (BBB) crossing strategies. Biomaterials 224, pages 119491.
Crossref
Waranyoo Phoolcharoen, Ashley C. Banyard, Christophe Prehaud, David Selden, Guanghui Wu, Colin P.D. Birch, Tim H. Szeto, Monique Lafon, Anthony R. Fooks & Julian K.-C. Ma. (2019) In vitro and in vivo evaluation of a single chain antibody fragment generated in planta with potent rabies neutralisation activity. Vaccine 37:33, pages 4673-4680.
Crossref
Chen Fu, Yonggang Xiang, Xiaorong Li & Ailing Fu. (2018) Targeted transport of nanocarriers into brain for theranosis with rabies virus glycoprotein-derived peptide. Materials Science and Engineering: C 87, pages 155-166.
Crossref
Waranyoo Phoolcharoen, Christophe Prehaud, Craig J. van Dolleweerd, Leonard Both, Anaelle da Costa, Monique Lafon & Julian K-C. Ma. (2017) Enhanced transport of plant-produced rabies single-chain antibody-RVG peptide fusion protein across an in cellulo blood-brain barrier device . Plant Biotechnology Journal 15:10, pages 1331-1339.
Crossref
Renato Mancini Astray, Soraia Attie Calil Jorge & Carlos Augusto Pereira. (2016) Rabies vaccine development by expression of recombinant viral glycoprotein. Archives of Virology 162:2, pages 323-332.
Crossref
Zhiyuan Zou, Zhaolin Sun, Pan Li, Tao Feng & Sen Wu. (2016) Cre Fused with RVG Peptide Mediates Targeted Genome Editing in Mouse Brain Cells In Vivo. International Journal of Molecular Sciences 17:12, pages 2104.
Crossref
Paul A. Gramlich, Wendy Westbroek, Ricardo A. Feldman, Ola Awad, Nicholas Mello, Mary P. Remington, Ying Sun, Wujuan Zhang, Ellen Sidransky, Michael J. Betenbaugh & Paul S. Fishman. (2016) A peptide-linked recombinant glucocerebrosidase for targeted neuronal delivery: Design, production, and assessment. Journal of Biotechnology 221, pages 1-12.
Crossref
Shane Miersch & Sachdev S. Sidhu. (2016) Intracellular targeting with engineered proteins. F1000Research 5, pages 1947.
Crossref
Benjamí Oller-Salvia, Macarena Sánchez-Navarro, Ernest Giralt & Meritxell Teixidó. (2016) Blood–brain barrier shuttle peptides: an emerging paradigm for brain delivery. Chemical Society Reviews 45:17, pages 4690-4707.
Crossref
Rebecca L. Cook, Kyle T. Householder, Eugene P. Chung, Alesia V. Prakapenka, Danielle M. DiPerna & Rachael W. Sirianni. (2015) A critical evaluation of drug delivery from ligand modified nanoparticles: Confounding small molecule distribution and efficacy in the central nervous system. Journal of Controlled Release 220, pages 89-97.
Crossref
Nian-Qiu Shi, Xian-Rong Qi, Bai Xiang & Yong Zhang. (2014) A survey on “Trojan Horse” peptides: Opportunities, issues and controlled entry to “Troy”. Journal of Controlled Release 194, pages 53-70.
Crossref
Xiang Yi, Devika S. Manickam, Anna Brynskikh & Alexander V. Kabanov. (2014) Agile delivery of protein therapeutics to CNS. Journal of Controlled Release 190, pages 637-663.
Crossref
Dietmar Benke. (2013) GABAB receptor trafficking and interacting proteins: Targets for the development of highly specific therapeutic strategies to treat neurological disorders?. Biochemical Pharmacology 86:11, pages 1525-1530.
Crossref
Ailing Fu, Miaomiao Zhang, Feiyan Gao, Xingran Xu & Zhangbao Chen. (2013) A Novel Peptide Delivers Plasmids across Blood-Brain Barrier into Neuronal Cells as a Single-Component Transfer Vector. PLoS ONE 8:3, pages e59642.
Crossref
Stefan R. Schmidt. 2013. Fusion Protein Technologies for Biopharmaceuticals. Fusion Protein Technologies for Biopharmaceuticals 383 395 .
Ailing Fu, Yilin Wang, Liping Zhan & Rumei Zhou. (2012) Targeted Delivery of Proteins into the Central Nervous System Mediated by Rabies Virus Glycoprotein-Derived Peptide. Pharmaceutical Research 29:6, pages 1562-1569.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.